Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Lexeo Therapeutics, Inc. (LXEO) had Pre-Tax Income of $-26.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-26.10M |
|
-- |
|
-- |
|
$30.69M |
|
$-30.69M |
|
$4.58M |
|
|
Pre-Tax Income |
$-26.10M |
$-29.49M |
|
$-26.10M |
|
$-26.10M |
|
$-26.10M |
|
$-29.49M |
|
$-30.69M |
|
$-30.58M |
|
43.57M |
|
43.57M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$140.06M |
|
$1.11M |
|
$36.01M |
|
$176.07M |
|
$31.59M |
|
$0.58M |
|
$6.26M |
|
$37.85M |
|
$138.22M |
|
$138.22M |
|
$138.22M |
|
54.00M |
|
| Cash Flow Statement Financials | |
$-48.94M |
|
$-23.57M |
|
$72.97M |
|
$38.27M |
|
$38.73M |
|
$0.46M |
|
$6.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.43 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-49.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.89% |
|
-18.89% |
|
-14.83% |
|
-18.81% |
|
$2.56 |
|
$-1.13 |
|
$-1.12 |
|